Symrise gets new consumer unit
This article was originally published in The Tan Sheet
Executive Summary
Food and cosmetic ingredient manufacturer Symrise expands its portfolio by adding a consumer health business unit to include food supplements, health care and specialty products, the Holzminden, Germany-based firm says Nov. 24. The unit, headed by Dirk Bennwitz, senior VP of business consumer health, "will specialize in creating functional ingredients for food supplements and flavor solutions for health products," the firm said. Symrise's consumer health team will be a driving force in the corporation's health and nutrition strategy. Symrise CEO Heinze-Jürgen Bertram said the launch of the consumer unit is in response to the growing health and nutrition market
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.